These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11586051)

  • 1. Analysis of the metabolism of haloperidol and its neurotoxic pyridinium metabolite in patients with drug-induced parkinsonism.
    Iwahashi K; Anemo K; Nakamura K; Fukunishi I; Igarashi K
    Neuropsychobiology; 2001; 44(3):126-8. PubMed ID: 11586051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the metabolism of haloperidol (HP) and its neurotoxic pyridinium metabolite (HPP+) in patients with drug-induced parkinsonism.
    Iwahashi K; Anemo K; Nakamura K; Yoshihara E; Igarashi K
    Clin Chim Acta; 2000 Aug; 298(1-2):193-5. PubMed ID: 10979726
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
    Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
    J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia.
    Eyles DW; McLennan HR; Jones A; McGrath JJ; Stedman TJ; Pond SM
    Clin Pharmacol Ther; 1994 Nov; 56(5):512-20. PubMed ID: 7955815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem.
    Eyles DW; Avent KM; Stedman TJ; Pond SM
    Life Sci; 1997; 60(8):529-34. PubMed ID: 9042387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the conversion of haloperidol and its tetrahydropyridine dehydration product to potentially neurotoxic pyridinium metabolites by human liver microsomes.
    Usuki E; Pearce R; Parkinson A; Castagnol N
    Chem Res Toxicol; 1996 Jun; 9(4):800-6. PubMed ID: 8831826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection.
    Igarashi K; Castagnoli N
    J Chromatogr; 1992 Sep; 579(2):277-83. PubMed ID: 1429975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of haloperidol and its pyridinium metabolite on plasma membrane permeability and fluidity in the rat brain.
    Murata T; Maruoka N; Omata N; Takashima Y; Igarashi K; Kasuya F; Fujibayashi Y; Wada Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):848-57. PubMed ID: 17363126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
    Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
    J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain levels of the neurotoxic pyridinium metabolite HPP+ and extrapyramidal symptoms in haloperidol-treated mice.
    Crowley JJ; Ashraf-Khorassani M; Castagnoli N; Sullivan PF
    Neurotoxicology; 2013 Dec; 39():153-7. PubMed ID: 24107597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurotoxic pyridinium metabolites of haloperidol are substrates of human organic cation transporters.
    Kang HJ; Lee SS; Lee CH; Shim JC; Shin HJ; Liu KH; Yoo MA; Shin JG
    Drug Metab Dispos; 2006 Jul; 34(7):1145-51. PubMed ID: 16624869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: is HPTP an intermediate?
    Avent KM; Riker RR; Fraser GL; Van der Schyf CJ; Usuki E; Pond SM
    Life Sci; 1997; 61(24):2383-90. PubMed ID: 9399630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol: studies using [3H]HPP+.
    Kawashima H; Iida Y; Kitamura Y; Kiyono Y; Magata Y; Saji H
    Jpn J Pharmacol; 2002 Aug; 89(4):426-8. PubMed ID: 12233823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
    Jaanson P; Marandi T; Kiivet RA; Vasar V; Vään S; Svensson JO; Dahl ML
    Psychopharmacology (Berl); 2002 Jun; 162(1):67-73. PubMed ID: 12107620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring haloperidol exposure in body fluids and hair of children by liquid chromatography-high-resolution mass spectrometry.
    Favretto D; Stocchero G; Nalesso A; Vogliardi S; Boscolo-Berto R; Montisci M; Ferrara SD
    Ther Drug Monit; 2013 Aug; 35(4):493-501. PubMed ID: 23851906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol.
    Subramanyam B; Pond SM; Eyles DW; Whiteford HA; Fouda HG; Castagnoli N
    Biochem Biophys Res Commun; 1991 Dec; 181(2):573-8. PubMed ID: 1755839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of a neurotoxic quaternary pyridinium metabolite in the liver of haloperidol-treated rats.
    Ablordeppey SY; Borne RF
    Pharmacol Biochem Behav; 1993 Nov; 46(3):739-44. PubMed ID: 8278454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant dose effect of carbamazepine on reduction of steady-state plasma concentration of haloperidol in schizophrenic patients.
    Yasui-Furukori N; Kondo T; Mihara K; Suzuki A; Inoue Y; Kaneko S
    J Clin Psychopharmacol; 2003 Oct; 23(5):435-40. PubMed ID: 14520118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.